Stone Bond Technologies EE-LIMS (Enterprise Enabler(R) Laboratory Information Management Systems) Earns Genechip-Compatible(TM) Status With The Affymetrix Genechip(R) Microarray
Stone Bond Technologies, a leading provider of laboratory information management and data integration systems, announced today that its Enterprise Enabler® and EE-LIMS systems have achieved GeneChip-compatible™ status with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform for gene expression and genetic variation analysis in biomedical research and development.
As a GeneChip-compatible software provider and participant in the Affymetrix GeneChip-compatible Applications Program, Stone Bond’s Enterprise Enabler integrates seamlessly with the Affymetrix GeneChip microarray platform. As a result, laboratories can automate sample data import and test result outflow to and from the Affymetrix GeneChip Operating Software (GCOS) using Stone Bond’s EE-LIMS system, saving time, reducing errors and lowering lab administrative costs.
“Today’s lab manager is under increasing pressure to reduce administrative costs and improve efficiencies and lab economics,” noted Stone Bond President and Chief Executive Officer Antonio Szabó. “As genetic research becomes more complex, technology that delivers automation compatibility to leverage existing capital investments in the lab provides additive value to streamline operations and help manage research overhead costs. We are honored that Affymetrix, the world leader in genetic research technology, has recognized Stone Bond’s EE-LIMS system as a compatible solution to work in partnership with their GeneChip platform.”
“As Affymetrix customers continue to scale up and industrialize their GeneChip microarray experiments for biomedical research, LIMS systems will become more and more important,” said Steve Lincoln, vice president of Informatics at Affymetrix. “We are pleased to be working with Stone Bond to provide critical data handling and processing in an automated manner.”
ABOUT STONE BOND TECHNOLOGIES
Stone Bond is a leader in automated laboratory information systems and application integration, providing software solutions that help healthcare, pharmaceutical, and biotech research facilities improve the quality of their research management while reducing their administration costs. Stone Bond’s software suite, Enterprise Enabler® is a commercially proven technology that significantly compresses delivery times and implementation costs. Our lab customer base includes MD Anderson Cancer Center, Baylor College of Medicine, Precision Biomarker Resources and Weill Medical College of Cornell University. For more information, contact Stone Bond by calling +1 713 622 8798, or visit us at www.stonebond.com
ABOUT THE AFFYMETRIX DEVELOPERS’ NETWORK (ADN)
Through one of the largest third-party software developer communities within the life science industry, Affymetrix works with its partners to provide a broad spectrum of solutions for leveraging gene expression and genetic variation analysis in both biomedical research and development. Membership in ADN is free of charge for both commercial and academic software developers. For more information please visit www.affymetrix.com/genechip/developer . View the GeneChip-compatible Software Solutions Catalog at www.affymetrix.com/genechip/compatible .
ABOUT AFFYMETRIX
Affymetrix scientists invented the world’s first microarray in 1989 and began selling the first commercial microarray in 1994. Since then, Affymetrix GeneChip® technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world’s top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. More than 1,400 systems have been shipped around the world and more than 4,000 peer-reviewed papers have been published using the technology. Affymetrix’ patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyze the relationship etween genetics and health. Headquartered in Santa Clara, Calif., Affymetrix has subsidiaries in Europe and Asia in addition to manufacturing facilities in Sacramento, Calif. and Bedford, Mass. The company has about 1,000 employees worldwide. For more information about Affymetrix, please visit the company’s website at www.Affymetrix.com .
